CAS No.: | 102767-28-2 |
---|---|
Formula: | C8h14n2o2 |
EINECS: | 102767-28-2 |
Type: | Synthesis Material Intermediates |
Appearance: | Powder |
Quality: | Refined |
Customization: |
---|
Suppliers with verified business licenses
Levetiracetam is suitable for assistant treatment of partial or secondary generalized epileptic seizures in adult epilepsy patients.
1) Levetiracetam has been approved in the European Union as a monotherapy treatment for epilepsy in the case
of partial seizures
2) Levetiracetam has potential benefits for other psychiatric and neurologic conditions such as Tourette syndrome
3) It is also sometimes used to treat neuropathic pain
Product Name | Levetiracetam |
CAS | 102767-28-2 |
MF | C8H14N2O2 |
EINECS | 600-348-9 |
Melting point | 118-119°C |
Storage conditions | 2-8°C |
Melting point | 118-119°C |
alpha | -89.7 º |
Fp | 9ºC |
storage temp. | 2-8°C |
solubility | H2O: >5mg/mL |
form | powder |
color | white |
optical activity | [α]/D -90±5°, c = 1 in ace tone |
InChIKey | HPHUVLMMVZITSG-UHFFFAOYSA-N |
CAS DataBase Reference | 102767-28-2(CAS DataBase Reference) |
Suppliers with verified business licenses